BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18708243)

  • 1. Neoadjuvant chemotherapy followed by radical surgery in patients affected by vaginal carcinoma.
    Benedetti Panici P; Bellati F; Plotti F; Di Donato V; Antonilli M; Perniola G; Manci N; Muzii L; Angioli R
    Gynecol Oncol; 2008 Nov; 111(2):307-11. PubMed ID: 18708243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy followed by radical surgery in patients affected by FIGO stage IVA cervical cancer.
    Benedetti Panici P; Bellati F; Manci N; Pernice M; Plotti F; Di Donato V; Calcagno M; Zullo MA; Muzii L; Angioli R
    Ann Surg Oncol; 2007 Sep; 14(9):2643-8. PubMed ID: 17562114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma.
    Zanetta G; Lissoni A; Gabriele A; Landoni F; Colombo A; Perego P; Mangioni C
    Gynecol Oncol; 1997 Mar; 64(3):431-5. PubMed ID: 9062145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports.
    Chun KC; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Jpn J Clin Oncol; 2010 Jul; 40(7):694-8. PubMed ID: 20427545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report.
    Plante M; Lau S; Brydon L; Swenerton K; LeBlanc R; Roy M
    Gynecol Oncol; 2006 May; 101(2):367-70. PubMed ID: 16542714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
    Maneo A; Chiari S; Bonazzi C; Mangioni C
    Gynecol Oncol; 2008 Dec; 111(3):438-43. PubMed ID: 18835493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy and vaginal radical trachelectomy for fertility-sparing treatment in women affected by cervical cancer (FIGO stage IB-IIA1).
    Marchiole P; Tigaud JD; Costantini S; Mammoliti S; Buenerd A; Moran E; Mathevet P
    Gynecol Oncol; 2011 Sep; 122(3):484-90. PubMed ID: 21636113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cervical cancer in Italy: strategies and their impact on the women.
    De Vincenzo R; Amadio G; Ricci C; Licameli A; Ferrandina G; Capelli G; Scambia G
    Vaccine; 2009 May; 27 Suppl 1():A39-45. PubMed ID: 19480960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer.
    Bae JH; Lee SJ; Lee A; Park YG; Bae SN; Park JS; Namkoong SE
    Gynecol Oncol; 2008 Dec; 111(3):444-8. PubMed ID: 18829085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer.
    Chakravarthy AB; Kelley MC; McLaren B; Truica CI; Billheimer D; Mayer IA; Grau AM; Johnson DH; Simpson JF; Beauchamp RD; Jones C; Pietenpol JA
    Clin Cancer Res; 2006 Mar; 12(5):1570-6. PubMed ID: 16533783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.
    Pecorelli S; Favalli G; Gadducci A; Katsaros D; Panici PB; Carpi A; Scambia G; Ballardini M; Nanni O; Conte P;
    J Clin Oncol; 2009 Oct; 27(28):4642-8. PubMed ID: 19704064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement.
    DeMartelaere SL; Roberts D; Burgess MA; Morrison WH; Pisters PW; Sturgis EM; Ho V; Esmaeli B
    Head Neck; 2008 May; 30(5):639-46. PubMed ID: 18213722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
    Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
    Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients.
    Di Lorenzo G; Cartenì G; Autorino R; Gonnella A; Perdonà S; Ferro M; Longo N; Rescigno P; Doria F; Faiella A; Altieri V; Palmieri G; Imbimbo C; Mirone V; De Placido S
    Anticancer Drugs; 2009 Apr; 20(4):277-80. PubMed ID: 19262371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy.
    Demaria S; Volm MD; Shapiro RL; Yee HT; Oratz R; Formenti SC; Muggia F; Symmans WF
    Clin Cancer Res; 2001 Oct; 7(10):3025-30. PubMed ID: 11595690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer.
    Loizzi V; Cormio G; Vicino M; Selvaggi L
    Gynecol Obstet Invest; 2008; 65(2):96-103. PubMed ID: 17878736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
    Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T
    Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A less radical treatment option to the fertility-sparing radical trachelectomy in patients with stage I cervical cancer.
    Rob L; Pluta M; Strnad P; Hrehorcak M; Chmel R; Skapa P; Robova H
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S116-20. PubMed ID: 18725167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.